Steven D. Harr

2022 - Sana Biotechnology

In 2022, Steven D. Harr earned a total compensation of $3.8M as President, Chief Executive Officer, and Director at Sana Biotechnology, a 221% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$389,063
Option Awards$2,770,084
Salary$644,832
Other$4,000
Total$3,807,978

Harr received $2.8M in option awards, accounting for 73% of the total pay in 2022.

Harr also received $389.1K in non-equity incentive plan, $644.8K in salary and $4K in other compensation.

Rankings

In 2022, Steven D. Harr's compensation ranked 927th out of 5,683 executives tracked by ExecPay. In other words, Harr earned more than 83.7% of executives.

ClassificationRankingPercentile
All
927
out of 5,683
84th
Division
Manufacturing
423
out of 3,091
86th
Major group
Chemicals And Allied Products
152
out of 1,406
89th
Industry group
Drugs
138
out of 1,307
89th
Industry
Biological Products, Except Diagnostic Substances
32
out of 295
89th
Source: SEC filing on April 28, 2023.

Harr's colleagues

We found two more compensation records of executives who worked with Steven D. Harr at Sana Biotechnology in 2022.

2022

Bernard Cassidy

Sana Biotechnology

General Counsel

2022

Sunil Agarwal

Sana Biotechnology

Chief Medical Officer

News

In-depth

You may also like